Aripiprazole induced myopia - case report and literature review: Aripiprazole induced myopia.

Tânia Abreu, Joana Pinheiro
{"title":"Aripiprazole induced myopia - case report and literature review: Aripiprazole induced myopia.","authors":"Tânia Abreu, Joana Pinheiro","doi":"10.3371/CSRP.TAJP.121218","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Aripiprazole is an antipsychotic used in the treatment of different disorders. The most common side effects are dizziness, insomnia, akathisia, activation, nausea and vomiting. Ophthalmologic side effects are rare. We report a case of myopia induced by aripiprazole.</p><p><strong>Methods: </strong>Case study and literature review on aripiprazole-induced myopia.</p><p><strong>Results: </strong>a 21-year-old male, with a first psychotic episode, developed myopia two weeks after initiating aripiprazole 20 mg/day. The symptoms of blurred vision were solved eight to ten days after switching to paliperidone. To date, seven cases of aripiprazole-induced myopia were reported in literature, all of them related to the oral formulation.</p><p><strong>Discussion: </strong>in the present case, as seen in seven previously reported cases, the patient presented with myopia after the initiation of aripiprazol and the problem was solved after discontinuation of the drug. Apparently, this effect is not dose dependent, since the eight patients described were medicated with different dosages, from 3 to 20 mg per day. The onset of the symptoms was within a month, from three to thirty days, and the resolution after discontinuation was reported to be from three to fourteen days. Psychiatrists and ophthalmologists should be alert to the possibility of aripiprazole-induced myopia. When an ophthalmologist detects this problem, the patient should be referred to his psychiatrist to proceed with the prescription changes.</p>","PeriodicalId":40019,"journal":{"name":"Clinical Schizophrenia and Related Psychoses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Schizophrenia and Related Psychoses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3371/CSRP.TAJP.121218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Aripiprazole is an antipsychotic used in the treatment of different disorders. The most common side effects are dizziness, insomnia, akathisia, activation, nausea and vomiting. Ophthalmologic side effects are rare. We report a case of myopia induced by aripiprazole.

Methods: Case study and literature review on aripiprazole-induced myopia.

Results: a 21-year-old male, with a first psychotic episode, developed myopia two weeks after initiating aripiprazole 20 mg/day. The symptoms of blurred vision were solved eight to ten days after switching to paliperidone. To date, seven cases of aripiprazole-induced myopia were reported in literature, all of them related to the oral formulation.

Discussion: in the present case, as seen in seven previously reported cases, the patient presented with myopia after the initiation of aripiprazol and the problem was solved after discontinuation of the drug. Apparently, this effect is not dose dependent, since the eight patients described were medicated with different dosages, from 3 to 20 mg per day. The onset of the symptoms was within a month, from three to thirty days, and the resolution after discontinuation was reported to be from three to fourteen days. Psychiatrists and ophthalmologists should be alert to the possibility of aripiprazole-induced myopia. When an ophthalmologist detects this problem, the patient should be referred to his psychiatrist to proceed with the prescription changes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿立哌唑诱发近视--病例报告和文献综述:阿立哌唑诱发近视。
简介阿立哌唑是一种抗精神病药物,用于治疗不同的疾病。最常见的副作用是头晕、失眠、运动失调、兴奋、恶心和呕吐。眼科副作用比较罕见。我们报告了一例阿立哌唑诱发近视的病例:结果:一名首次精神病发作的21岁男性在服用阿立哌唑20毫克/天两周后出现近视。在改用帕利哌酮治疗8至10天后,视力模糊的症状得到缓解。迄今为止,文献中报道了七例阿立哌唑诱发近视的病例,均与口服制剂有关。讨论:在本病例中,与之前报道的七例病例一样,患者在开始服用阿立哌唑后出现近视,停药后问题得到解决。显然,这种影响与剂量无关,因为上述八名患者的用药剂量各不相同,从每天 3 毫克到 20 毫克不等。症状在一个月内出现,从 3 天到 30 天不等,停药后症状消失的时间据说从 3 天到 14 天不等。精神科医生和眼科医生应警惕阿立哌唑诱发近视的可能性。当眼科医生发现这一问题时,应将患者转介给精神科医生,以便更换处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Schizophrenia and Related Psychoses
Clinical Schizophrenia and Related Psychoses Medicine-Psychiatry and Mental Health
自引率
0.00%
发文量
0
期刊介绍: The vision of the exciting new peer-reviewed quarterly publication Clinical Schizophrenia & Related Psychoses (CS) is to provide psychiatrists and other healthcare professionals with the latest research and advances in the diagnosis and treatment of schizophrenia and related psychoses. CS is a practice-oriented publication focused exclusively on the newest research findings, guidelines, treatment protocols, and clinical trials relevant to patient care.
期刊最新文献
Dysexecutive Behavior in First-Episode Schizophrenia. Dysexecutive Behavior in First-Episode Schizophrenia Grading meningiomas by used imaging features on magnetic resonance imaging The Association between Serum Levels of Ferritin and D-Dimer with Liver Function Tests in Patients with COVID-19 Role of Susceptibility Weighted Magnetic Resonance Imaging in Neurological Diagnosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1